• Clinically approved drugs could disrupt SARS-CoV-2 from hijacking Cells

    13 days ago - By News Medical

    An international team of researchers has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells.
    Read more ...

     

  • Our Dogged Adventure Up North

    Our Dogged Adventure Up North

    13 days ago - By MedPageToday

    This week, after working mostly nonstop over the past 5 or 6 months taking care of really nothing but COVID-19 patients in New York City, I finally decided that I needed a couple days off work. I was definitely feeling the stress...
    Read more ...

     

  • Treatments Linked to Death in COVID Patients With Thoracic Cancers

    13 days ago - By Medscape

    Past treatment may affect the risk of death among patients with thoracic malignancies who develop COVID-19, according to data from the TERAVOLT registry.
    Medscape Medical News
    Read more ...

     

  • Hard-Hit US States 'Surge' Hospital Intensive Care Beds as ICU Wards Fill Up

    13 days ago - By Medscape

    Some Texas hospitals are running out of intensive care unit beds for COVID-19 patients, turning to surge capacity that they expect will let them handle rising virus cases for another couple of weeks.
    Reuters Health Information
    Read more ...

     

  • RCSI begins clinical trial of promising therapy for critically ill COVID-19 patients

    14 days ago - By News Medical

    Clinician scientists at RCSI University of Medicine and Health Sciences have begun a clinical trial of a promising therapy for critically ill COVID-19 patients in intensive care.
    Read more ...

     

  • Gilead Prices COVID-19 Drug Candidate Remdesivir at $2,340 Per Patient

    14 days ago - By Medscape

    Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a 5-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.
    Reuters Health Information
    Read more ...